Amino acid polymorphisms in human histocompatibility leukocyte antigen class II and proinsulin epitope have impacts on type 1 diabetes mellitus induced by immune-checkpoint inhibitors.
Inaba H, Morita S, Kosugi D, Asai Y, Kaido Y, Ito S, Hirobata T, Inoue G, Yamamoto Y, Jinnin M, Kimura H, Ota M, Okudaira Y, Nakatani H, Kobayashi T, Iwama S, Arima H, Matsuoka T.
Inaba H, et al. Among authors: ota m.
Front Immunol. 2023 Apr 6;14:1165004. doi: 10.3389/fimmu.2023.1165004. eCollection 2023.
Front Immunol. 2023.
PMID: 37114039
Free PMC article.